Dark | Light
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

![EisaiGlobalOnc Avatar](https://lunarcrush.com/gi/w:24/cr:twitter::1397558872404017152.png) Eisai Oncology Medical [@EisaiGlobalOnc](/creator/twitter/EisaiGlobalOnc) on x 1259 followers
Created: 2025-07-10 14:43:17 UTC

Enrollment is now open for our randomized dose optimization study
of E7386 in combination with other anticancer drug(s) in patients with endometrial carcinoma.
#oncology #EC


XXX engagements

![Engagements Line Chart](https://lunarcrush.com/gi/w:600/p:tweet::1943320124968349841/c:line.svg)

**Related Topics**
[drugs](/topic/drugs)
[$4523t](/topic/$4523t)

[Post Link](https://x.com/EisaiGlobalOnc/status/1943320124968349841)

[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

EisaiGlobalOnc Avatar Eisai Oncology Medical @EisaiGlobalOnc on x 1259 followers Created: 2025-07-10 14:43:17 UTC

Enrollment is now open for our randomized dose optimization study of E7386 in combination with other anticancer drug(s) in patients with endometrial carcinoma. #oncology #EC

XXX engagements

Engagements Line Chart

Related Topics drugs $4523t

Post Link

post/tweet::1943320124968349841
/post/tweet::1943320124968349841